USD $6.00-9.00 / Gram
USD $5.00-10.00 / Gram
USD $6.00-9.00 / Gram
USD $6.00-9.00 / Gram
USD $5.00-10.00 / Gram
USD $6.00-9.00 / Gram
USD $5.00-10.00 / Gram
USD $5.00-10.00 / Gram
USD $5.00-10.00 / Gram
wuliangye group yibin pharmaceutical co.,ltd was established in 1969 and covers an total area of over 220000 square meters. yibin pharmaceutical co., ltd is a gmp approved enterprise and mainly produced formulation of chinese medicine, apis, biological agents, and pharmaceutical intermediates.
1. pharmaceutical manufacturer with super quality by reasonable price.
2. fast delivery by safe express way to all the country.
3. has a number of highlty qualified engineers and experts to provide guidance for reagents.
4. free samples and coas can be provided.
5. trandolapril is our featured product which we can provide professional guidance and mature production process. you are also very welcome to audit at sight.
welcome to contact us for more products information and requirement, i will send our product list for your choose. looking forward to our long term cooperation.
main product: ketoprofen, l'ornithne l'aspartate, octreotide acetate, nevirapine, diacerein, pramipexole dihydrochloride, esomeprazole sodium, trandolapril, capecitabine, zoledronic acid, moxifloxacin hydrochloride, febuxostat, potassium dehydroandrograpolide succinate, 5-azacytosine, 2-(3-benzoylphenyl) propionitrile, intermediate of capecitabine, andrographolide, etc.
contact person: pointy wang
contact email: yibinpharma@163.com
tel: +86-0831-5109854
qq: 50144792
skype: yibinpharma@163.com
products name: trandolapril
trandolapril cas no.87679-37-6
trandolapril synonyms:
gopten; odrik; 1-ethyl ester (2s,3ar,7as)-1-[(s)-n-[(s)-1-carboxy- 3-phenylpropyl] alanyl]hexahydro-2-indolinecarboxylic acid; 1h-indole-2-carboxylicacid,1-[(2s)-2-[[(1s)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-,(2s,3ar,7as)-
trandolapril main functions:
management of hypertension (alone or in combination with other classes of antihypertensive agents); reduction of the risk of heart failure or left ventricular dysfunction after ami; management of symptomatic chf; a first-line agent in the treatment of diabetic nephropathy.
trandolapril inchi:
inchi=1s/c24h34n2o5/c1-3-31-24(30)19(14-13-17-9-5-4-6-10-17)25-16(2)22(27)26-20-12-8-7-11-18(20)15-21(26)23(28)29/h4-6,9-10,16,18-21,25h,3,7-8,11-15h2,1-2h3,(h,28,29)/t16-,18+,19-,20-,21-/m0/s1
molecular formula:c24h34n2o5
trandolapril molecular weight:491.08g/mol
trandolapril density: 1.181g/cm3
melting point: 122-123℃
trandolapril boiling point: 636℃ at 760mmhg
refractive index: 1.549
flash point: 332.4℃
trandolapril insolubilities: insoluble in water
trandolapril storage temperature: room temperature
trandolapril appearance: trandolapril is white powder
package: 25kg/drum
assay: ≧99%